Skip to content
10-Q

Quarterly Report

CERO THERAPEUTICS HOLDINGS, INC. CERO CEROW

0001213900-25-112619

← back to feed
Filed
Nov 19, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 19, 2025 21.1M sh
Shares Diluted Q3 2025 · Sep 30, 2025 1.26M sh
Shares Diluted Q3 2025 · Sep 30, 2025 645.45K sh
Dividends Paid Q3 2025 · Sep 30, 2025 $127.14K
Cash And Equivalents Q3 2025 · Sep 30, 2025 $1.9M
Stockholders Equity Q3 2025 · Sep 30, 2025 −$4.54M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$1.89M
Current Liabilities Q3 2025 · Sep 30, 2025 $8.45M
Current Liabilities Q3 2025 · Dec 31, 2024 $7.4M
Total Liabilities Q3 2025 · Sep 30, 2025 $8.45M
Total Liabilities Q3 2025 · Dec 31, 2024 $8.1M
Current Assets Q3 2025 · Sep 30, 2025 $2.55M
Current Assets Q3 2025 · Dec 31, 2024 $3.71M
Total Assets Q3 2025 · Sep 30, 2025 $3.91M
Total Assets Q3 2025 · Dec 31, 2024 $6.21M
Eps Diluted Q3 2025 · Sep 30, 2025 −$9.10
Eps Diluted Q3 2025 · Sep 30, 2025 −$72.94
Eps Basic Q3 2025 · Sep 30, 2025 −$9.10
Eps Basic Q3 2025 · Sep 30, 2025 −$72.94
Sga Expense Q3 2025 · Sep 30, 2025 $1.98M
Sga Expense Q3 2025 · Sep 30, 2025 $5.99M
Rd Expense Q3 2025 · Sep 30, 2025 $2.39M
Rd Expense Q3 2025 · Sep 30, 2025 $8.05M
Net Income Q3 2025 · Sep 30, 2025 −$4.86M
Net Income Q3 2025 · Sep 30, 2025 −$15.38M
Net Income Q3 2025 · Jun 30, 2025 −$5.42M
Net Income Q3 2025 · Jun 30, 2024 −$2.45M
Operating Income Q3 2025 · Sep 30, 2025 −$4.36M
Operating Income Q3 2025 · Sep 30, 2025 −$14.04M